D
9 -tetrahydrocannabivarin, and cannabidivarin are the most studied 5 . These have different pharmacological actions from D 9 -THC and might even antagonize some of its actions [6] [7] [8] [9] . Cannabinoids act on at least two types of G protein coupled receptors; CB1 receptor predominantly expressed in the central nervous system and CB2 receptor predominantly expressed on immune cells in the periphery 10 .
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Only recently, cannabis and cannabinoidbased medicines have come to attention as a remedy for different medical conditions. The oromucosal spray Sativex, composed of whole plant extract containing both D 9 -THC and cannabidiol (CBD) [THC:CBD=1:1] is being used for the treatment of spasticity, neuropathic pain and bladder dysfunction in multiple sclerosis 11 . Dronabinol and nabilone are two oral formulations of a synthetic THC approved for treatment of nausea and vomiting due to chemotherapy and that refractory to conventional antiemetic therapy as well as weight loss associated with HIV infection and cancer 12, 13 . Medicinal cannabis is also being used for a variety of medical conditions including chronic pain, fibromyalgia, depression, arthritis, neuropathy [14] [15] [16] , and inflammatory bowel disease 18 . The use of cannabis is also frequent among epileptic patients and in one study 20 .3% of patients reported using cannabis after the diagnosis of epilepsy has been made 19 . The brain tissue is vulnerable to oxidative damage. The high rate of oxygen consumption and the presence of redox active metals such as Fe ++ and Cu ++ account for an increased generation of reactive oxygen/nitrogen metabolites. Meanwhile, the brain is rich in polyunsaturated fatty acids, the target of these reactive species. On the other hand, there are limited antioxidant mechanisms compared with other organs 20, 21 . It is not surprising therefore that oxidative stress is a major contributing pathogenetic factor in neurodegenerative disorders such as Parkinson's disease 22 , Alzheimer's disease 23 , Huntington' disease 24 , and Autism 25 . Oxidative stress has also been implicated in the development of epileptic seizures and/or neuronal damage in epilepsy [26] [27] [28] [29] [30] . Moreover, in experimental models of epilepsy, the administration of antioxidants eg., caffeine or ascorbic acid were shown to ameliorate lipid peroxidation in the brain tissue and the development of epileptic seizures [31] [32] [33] [34] . In this study, the effect of Cannabis sativa extract was examined on brain oxidative stress and epileptic seizures induced by the repeated administration of pentylenetetrazole (PTZ) in rats. Kindling caused by PTZ, a GABA(A) receptor antagonist is a clinically relevant model of human epilepsy 35 .
Materials and Methods animals
The study was conducted on male Sprague-Dawley rats weighing 180-200 g. Rats were group-housed under temperature-and light-controlled conditions and allowed standard laboratory rodent chow and water ad libitum. The experiments were done at 9 O'clock to avoid changes in circadian rhythm. .
Chemical kindling
The kindling procedure was induced by repeated ip injection of (35 mg/kg) of pentylenetetrazole (PTZ) (Sigma, St. Louis, USA) every 48 hours. After each PTZ treatment, rats were placed separately under glass funnels, and the appearance of clonic and tonic seizures were recorded during individual observations for 20 minutes. The resultant seizures were classified according to the following scale Rats were randomly divided into three groups (7-8 rats each). Rats were treated with 0.9% saline (group 1), PTZ at 35 mg/kg, ip, once every 48 hours for 12 times alone (group 2: control postive) with saline or with ip Cannabis sativa at 20 mg/kg (expressed as D 9 -THC content) 30 min prior to PTZ injection (group 3). Seizures were recorded for 20 minutes. Two hour after the last PTZ injection, rats were quickly euthanized by decapitation; their brains removed on ice cold glass plate, stored at -80°C until the biochemical assays. One half of each brain was kept in 10% formol saline for histopathological processing.
Biochemical assays determination of lipid peroxidation
Malondialdehyde (MDA), a product of lipid peroxidation was determined in tissue homogenates according to the method of Nair and Turne 38 . In this assay thiobarbituric acid reactive substances (TBA) react with thiobarbituric acid to form TBA-MDA adduct which can be measured colorimetrically at 532 nm.
determination of reduced glutathione
Reduced glutathione (GSH) was determined in tissue homogenates using the procedure of Ellman et al. 39 . The assay is based on the reduction of Ellman´s reagent (DTNB; 5, 5'-dithiobis (2-nitrobenzoic acid)) by the free sulfhydryl group on GSH to form yellow colored 5-thio-2-nitrobenzoic acid which can be determined using spectrophotometer at 412 nm.
determination of nitric oxide
Nitric oxide was determined using colorimetric assay where nitrate is converted to nitrite via nitrate reductase. Griess reagent then act to convert nitrite to a deep purple azo compound that can be determined using spectrophotometer 40 . 
determination of acetylcholinesterase activity
The procedure used was a modification of the method of Ellmanet al. 41 as described by Gorunet al. 42 . The principle of the method is the measurement of the thiocholine produced as acetylthiocholine is hydrolyzed. The color was read immediately at 412 nm.
statistical analysis
Results are expressed as mean ± SEM. The results of the biochemical assays analyzed using One Way ANOVA and Duncan's multiple range test while the results of behavioral study were analyzed by Mann-Whitney U test using Graphpad Prism software, version 5 (inc., San Diego, USA). A probability value of less than 0.05 was considered statistically significant.
results

Brain oxidative stress
Rats treated with PTZ exhibited significantly higher malondialdehyde (43 th and 7 th PTZ repeated injection during seizure development (Fig. 2) . Fig. 3 shows the average mean score over the study period. The mean seizure score was 2.52 ± 0.26 in the PTZ only group and 3.05 ± 0.24 in the PTZ + cannabis group (21% increase: p<0.05). Sections from the brain of saline-treated rats shows normal histological structure of the cerebral cortex (Fig. 6A) and cerebellum (Fig.  6B) . The cerebral cortex of rats treated with only PTZ exhibited spongiform changes, congestion of cerebral blood vessels, and hemorrhage in meninges above the surface. There were sings of degeneration and necrosis in some neurons and gliosis. Affected neurons became shrunken and eosinophilic. The nuclei became condensed and lost their crisp contours . Degeneration of Purkinje cells was observed (Fig. 6C & 5D ) became Rats treated with PTZ along with cannabis showed no improvement in pathological changes. Examination 5F ). In the cerebellum there was degeneration of some Purkinje cells after PTZ injections (Fig. 6G) . Following both PTZ and cannabis, the cerebellum showed degeneration of Purkinje cells and also thinning of the granular layer (Fig. 6H) .
disCussion
The results of the present study indicates that treatment with Cannabis sativa resin extract rich in D 9 -THC caused significant elevation of mean seizure scores in rats receiving PTZ, thereby, suggesting that cannabis increases the susceptibility for epileptic seizures. The administration of PTZ resulted in increased brain oxidative stress as indicated by the increase in the lipid peroxidation product malondialdehyde 21 , thereby, suggesting the increased production of reactive oxygen metabolites. The presence of oxidative stress and the increase in brain malondialdehyde in brain of rats treated with PTZ or other epileptogenic agents eg., pilocarpine has been reported previously 30, [43] [44] [45] . Studies also indicated increased lipid peroxidation in plasma of children with epilepsy and nuclear magnetic resonance changes 26 . Our results also show depletion of reduced glutathione by PTZ treatment. Glutathione, a tripeptide of l-glutamate, l-cyseine and l-glycine is the brain's most important antioxidant and free radical scavenger. The cysteine thiol moiety accounts for the antioxidant action of reduced glutathione and is oxidized by free radicals in the cell to oxidized GSH disulfide (GSSG) 46 and the ratio of its reduced (GSH)/oxidized (GSSG) form greatly determines the cellular redox state 46, 47 . The decrease in reduced glutathione in the brain of PTZ-treated rats thus occurs most probably as a result its consumption by the increased formation of reactive oxygen metabolites. Other studies found a significant decrease in GSH levels and in Cu,Zn-Superoxide dismutase and catalase activities in erythrocytes after PTZ injection in rats 27 . Significantly decreased GSH/water ratio was also found in the parietooccipital region of epileptic patients independently from seizure activity 48 . The present findings indicate markedly increased brain nitric oxide content following PTZ injections which is in accordance with other published data in kainic acid-or PTZ-induced seizures 49, 50 . The increase in nitric oxide of neuronal origin during seizure development has been implicated in the initiation of seizure-like events 51 and in causing endoplasmic reticulum stress and peroxynitite (ONOO-)-mediated oxidative/ nitrosative damage 45 . Moreover, inhibition of neuronal nitric oxide synthase was shown to inhibit convulsive seizures caused by PTZ in rats 50 . It is thought that this increase in nitrosative stress is involved in neurodegeneration seen in epilepsy 32, 52 . Our results shows in addition markedly depressed brain AChE activity in rats receiving PTZ. This inhibitory effect of PTZ on AChE activity has been reported in crude homogenates of rat brain 53 and an increase in cholinergic activity is linked to seizure initiation by the agent 54 . Acetylcholine release increases in the epileptic rat brain 55 and seizures could be induced in rodents by cholinergic agents like pilocarpine 30, 56 and organophosphorus nerve agents 57 . Abnormal AChE immunostaining and loss of AChE fibers have been demonstrated in some regions in specimens from temporal lobe epileptics 58 . Moreover, neuronal nicotinic receptor mutations have been implicated in autosomal dominant nocturnal frontal lobe epilepsy 59 . These data suggests a role for increased neuronal cholinergic activity in epileptogenesis.
In this study, the effect of Cannabis sativa resin extract rich in D 9 -THC on the development of brain oxidative stress and seizures due to PTZ was examined. Cannabis was shown to increase seizure severity. Other studies showed increased kindling due to PTZ, picrotoxin or electroshock by D 9 -THC in mice 60 . Recently, Malyshevskata et al. 61 reported the development of electrographic seizures in mice by administering D 9 -THC (10 mg/ kg) or the synthetic cannabinoid agonist JWH-018 with the effect being mediated by CB1 receptors. In humans, convulsions have been reported after the use of synthetic cannabinoids 62, 63 . We also found that treatment with cannabis resin was associated with an increase in brain malondialdehyde. Nitric oxide was unchanged but there was restoration of brain reduced glutathione by cannabis. This latter observation is intriguing for it suggests that the mere increased in reduced glutathione was not sufficient to inhibit lipid peroxidation in this model of brain damage. Moreover, our results show that the administration of cannabis resin increased brain AChE activity which is in accordance with previously published data 37 . Finally, we observed that cannabis did not decrease neuronal damage caused by repeated PTZ injections. Cannabis is a complex mixture of over 600 different compounds and beside terpenophenolic cammabinoids there are non-cannabinoid phenols, flavonoids eg, flavocannabiside and flavosativaside, flavonol glycosides such as kaempferol 3-O-sophoroside and quercetin 3-Osophoroside, and fatty acids 64, 65 . Concerning cannabinoids, these differ in their receptor pharmacology with D 9 -THC acting as a partial agonist of CB1 and CB2 receptors, while cannabidiol and D
9
-tetrahydrocannabivarin exhibits antagonistic effects 7, 9, 66 . Moreover, cannabigerol exerts alpha2-adrenoceptor agonist and 5HT1A receptor antagonist activities 67 . These facts makes the effect of the whole plant extract different from that of only D 9 -THC 68, 69 . In this study, however, D 9 -THC was the major cannabinoid identified in the extract, making it the most likely constituent that accounted for the observed effects of cannabis in this model of epilepsy.
In summary, the present study demonstrates that the use of Cannabis sativa resin extract rich in D 9 -THC results in increased sensitivity to PTZinduced seizures.
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